Developed by pioneer in the SPM market, Solutex, LIPINOVA® is a safe, effective, high quality and science-backed solution for the resolution of inflammation that offers several unique benefits.
LIPINOVA® SPMs are the result of extensive research and development in conjunction with leading specialists and universities. The foundation for LIPINOVA® is the unique combination of world-class fractionation and purification techniques applied to omega-3 rich oil. Learn more about our special scientific capabilities, including our advanced HDAS technology – the only tool in the market that accurately measures SPMs in biological samples.
LIPINOVA®’s safety and efficacy is proven in several published studies. Explore the latest research demonstrating the solution’s effects after supplementation, including its role in modulating the immune system towards resolution and improving inflammatory status with no side effects.
Nutrition 2021 – ASN Conference (Sponsored Satellite Symposium – Supplementation with Lipinova® SPMs)
Leukocytes from obese individuals exhibit an impaired SPM signature. López-Vicario et al. FASEB J., 2019.
Lipid-induced mechanisms of metabolic syndrome. Denisenko et al. J Obesity, 2020.
Resolvins, specialized pro-resolving lipid mediators and their potential roles in metabolic diseases. Spite et al. Cell Metab., 2014.
Treatment with a marine oil supplement alters lipid mediators and leukocyte phenotype in healthy patients and those with peripheral artery disease. Schaller et al. J Am Heart Assoc., 2020.
Specialized pro-resolving mediators in cardiovascular diseases. Fredman & Spite. Mol Aspects Med., 2017.
Catedra Solutex of Sustainable Chemistry, University of Zaragoza (May 2021). Discover the link between long-Covid and failed resolution of inflammation in our expert-led webinar, presented by Catedra Solutex of Sustainable Chemistry and the Fundación Areces – a non-profit organization aiming to stimulate and support scientific and technical research in Spain, and promote education and culture.
Stimulating the resolution of inflammation through omega-3 polyunsaturated fatty acids in COVID-19: rationale for the COVID-Omega-F Trail. Arnardottir et al. Front Physiol., 2021.
The specialized pro-resolving mediator 17-HDHA enhances the anibody-mediated immune response against influenza virus: a new class of adjuvant? Ramon et al. J Immunol., 2014.
Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? Panigrahy et al. Cancer Metastasis Rev., 2020.
3rd Nutrition in Athlete Development Online Summit (November 2021). Watch Dr. LeMay’s presentation on SPMs in sports recovery at the sponsored Symposium.
Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment. Markworth et al. Am J Physiol Regul Integr Comp Physiol., 2013.
Specialized pro-resolving mediators of inflammation in inflammatory arthritis. Barden et al. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2016.
Early evidence of efficacy for orally administered SPM enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain. Callan et al. J Transl Med., 2020.
Neuromodulation, specialized proresolving mediators, and resolution of pain. Tao et al. Neurotherapeutics, 2020.